Home -
Products -
Chromatin/Epigenetic -
Epigenetic Reader Domain -
2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
CAS No. 96680-77-2
2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one( —— )
Catalog No. M28385 CAS No. 96680-77-2
2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | 642 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
-
NoteResearch use only, not for human use.
-
Brief Description2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
-
Description2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorHuman Endogenous Metabolite|GPR109B|AhR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96680-77-2
-
Formula Weight193.26
-
Molecular FormulaC10H11NOS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1CC(=O)Nc2ccccc2S1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang XD, et al. A method for the determination of D-kynurenine in biological tissues. Anal Bioanal Chem. 2013 Dec;405(30):9747-54.
molnova catalog
related products
-
BAZ1A-IN-1
BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.
-
SMARCA-BD ligand 1 f...
SMARCA-BD ligand 1 for Protac is a compound that binds to SMARCA2, the BAF ATPase subunit, utilizing Protac technology to degrade SMARCA2.
-
GSK620
GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.
Cart
sales@molnova.com